Back to search

Article

The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal

2024-01-18

Abstract excerpt

<h4>Background: </h4> Breast cancer frequently leads to reduced work capacity and increased absenteeism among working-age women diagnosed with this condition. In this study, we aimed to assess the effect of CDK4/6i combined with aromatase inhibitors (AIs) or fulvestrant on quality of life (QoL) and work activity in a cohort of Portuguese patients with hormone receptor-positive/human epidermal growth factor recepto...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99173d33-c2b4-5c54-808b-1ab4e32f9d9a
DOI
10.12688/f1000research.142460.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from PortugalDOI 10.12688/f1000research.142460.1
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy.Semantic proximity
PRECYCLE: Multicenter, Randomized Phase IV Intergroup Trial to Evaluate the Impact of E Health-Based Patient Reported Outcome (PRO) Assessment on Quality of Life in Patients with Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Treated with Palbociclib and an Aromatase Inhibitor- or Palbociclib and FulvestrantSemantic proximity
Who Bears the Highest Costs of Breast Cancer? A Cost-of-Illness Study in Poland from a Societal PerspectiveSemantic proximity
Association between body composition parameters and treatment-related toxicities in patients with metastatic breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitorsSemantic proximity
Factors Associated with Health-Related Quality of Life Among Breast Cancer Survivors in the Saudi Arabia: Cross Sectional StudySemantic proximity
Interdependent Patient-Reported Outcome Patterns During Breast Cancer Pharmacotherapy: A Correlation-Based Analysis Using EORTC QLQ-C30 and QLQ-BR23Semantic proximity
Understanding return to work after a cancer-related sickness absence. Perceptions of barriers and facilitators among all relevant stakeholdersSemantic proximity
Higher Level of Sports Activities Participation During the Five-year Survival Was Associated With Better Quality of Life Among Chinese Breast Cancer SurvivorsSemantic proximity
Employment risks of all employed working-age cancer survivors after cancer diagnosis: a retrospective cohort analysis of population-based administrative dataSemantic proximity
Study of how Clinical and Sociodemographic Variables Influence Chemotherapy-Induced Cognitive Deterioration in Women with Breast CancerSemantic proximity
Study of How Clinical and Sociodemographic Variables Influence Chemotherapy-induced Cognitive Deterioration in Women with Breast CancerSemantic proximity
Study of how clinical and sociodemographic variables influence chemotherapy-induced cognitive deterioration in women with breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.